KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Senseonics Holdings (SENS) Long-Term Debt Issuances (2015 - 2024)

Senseonics Holdings (SENS) reported Long-Term Debt Issuances of $10.0 million for Q1 2024, down 72.18% on a QoQ basis from $35.8 million in Q3 2020.

Senseonics Holdings (SENS) has 7 years of Long-Term Debt Issuances data on file, last reported at $10.0 million in Q1 2024.

  • Quarterly Long-Term Debt Issuances changed N/A year-over-year to $10.0 million in Q1 2024, while the trailing twelve-month figure through Dec 2024 was $10.0 million (down 91.7% YoY) and the FY2024 annual result came in at $10.0 million, down 59.3% from the prior year.
  • Long-Term Debt Issuances fell to $10.0 million in Q1 2024 per SENS's latest filing, from $35.8 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $35.8 million in Q3 2020 and bottomed at $10.0 million in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 19.86 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 11.71 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 1.15 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Senseonics Holdings 316.18 Mn 251.85 Mn 6.94 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2024 9.95 Mn
Mar 31, 2024 9.95 Mn
Sep 30, 2020 35.77 Mn
Sep 30, 2020 35.77 Mn
Dec 31, 2019 84.05 Mn
Dec 31, 2019 84.05 Mn
Dec 31, 2018 2.25 Mn
Dec 31, 2018 2.25 Mn
Sep 30, 2018 -29,000.00
Sep 30, 2018 -29,000.00
Jun 30, 2018 -470,000.00
Jun 30, 2018 -470,000.00
Mar 31, 2018 51.20 Mn
Mar 31, 2018 51.20 Mn
Dec 31, 2017 104,000.00
Dec 31, 2017 104,000.00
Jun 30, 2017 -104,000.00
Jun 30, 2017 -104,000.00
Mar 31, 2017 5.00 Mn
Mar 31, 2017 5.00 Mn
Dec 31, 2016 5.00 Mn
Dec 31, 2016 5.00 Mn
Jun 30, 2016 15.00 Mn
Jun 30, 2016 15.00 Mn
Mar 31, 2016 2.50 Mn
Mar 31, 2016 2.50 Mn
Sep 30, 2015 9,000.00
Sep 30, 2015 9,000.00